APP and Alzheimer disease: Consistently, we observed Fzd1 and Fzd7 downregulation in the hippocampus of the overexpressing AD model APP/PS1 (Fig. S5M), but not in J20 (Fig. S5N) or other models [46], at a similar disease stage [47, 48].